53 related articles for article (PubMed ID: 31219645)
1. High B3GALT5 expression confers poor clinical outcome and contributes to tumor progression and metastasis in breast cancer.
Liao YM; Wang YH; Hung JT; Lin YJ; Huang YL; Liao GS; Hsu YL; Wu JC; Yu AL
Breast Cancer Res; 2021 Jan; 23(1):5. PubMed ID: 33413566
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells.
Liang YJ; Ding Y; Levery SB; Lobaton M; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):4968-73. PubMed ID: 23479608
[TBL] [Abstract][Full Text] [Related]
3. Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.
Cardiff RD; Couto S; Bolon B
Breast Cancer Res; 2011 Oct; 13(5):216. PubMed ID: 22067349
[TBL] [Abstract][Full Text] [Related]
4. Predictive bioinformatics identifies novel regulators of proliferation in a cancer stem cell model.
Fields E; Wren JD; Georgescu C; Daum JR; Gorbsky GJ
Stem Cell Res; 2018 Jan; 26():1-7. PubMed ID: 29179130
[TBL] [Abstract][Full Text] [Related]
5. miR-203 drives breast cancer cell differentiation.
Martínez-Illescas NG; Leal S; González P; Graña-Castro O; Muñoz-Oliveira JJ; Cortés-Peña A; Gómez-Gil M; Vega Z; Neva V; Romero A; Quintela-Fandino M; Ciruelos E; Sanz C; Aragón S; Sotolongo L; Jiménez S; Caleiras E; Mulero F; Sánchez C; Malumbres M; Salazar-Roa M
Breast Cancer Res; 2023 Aug; 25(1):91. PubMed ID: 37542268
[TBL] [Abstract][Full Text] [Related]
6. A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis.
Kim K; Kim S; Ahn T; Kim H; Shin SJ; Choi CH; Park S; Kim YB; No JH; Suh DH
BMC Cancer; 2023 Dec; 23(1):1215. PubMed ID: 38066476
[TBL] [Abstract][Full Text] [Related]
7. AFAP1L1 promotes gastric cancer progression by interacting with VAV2 to facilitate CDC42-mediated activation of ITGA5 signaling pathway.
Sun B; Ding B; Chen Y; Peng C; Chen X
J Transl Med; 2023 Jan; 21(1):18. PubMed ID: 36631800
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications.
Wang L; Jin Z; Master RP; Maharjan CK; Carelock ME; Reccoppa TBA; Kim MC; Kolb R; Zhang W
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805056
[TBL] [Abstract][Full Text] [Related]
9. Wnt Signaling in the Breast: From Development to Disease.
Abreu de Oliveira WA; El Laithy Y; Bruna A; Annibali D; Lluis F
Front Cell Dev Biol; 2022; 10():884467. PubMed ID: 35663403
[TBL] [Abstract][Full Text] [Related]
10. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
Lv L; Shi Y; Wu J; Li G
Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
[TBL] [Abstract][Full Text] [Related]
11. Members of the miR-30 family inhibit the epithelial-to-mesenchymal transition of non-small-cell lung cancer cells by suppressing XB130 expression levels.
Song K; Jiang Y; Zhao Y; Xie Y; Zhou J; Yu W; Wang Q
Oncol Lett; 2020 Oct; 20(4):68. PubMed ID: 32863901
[TBL] [Abstract][Full Text] [Related]
12. The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth.
Hu X; Ding J; Wang G; Zhang X
J Int Med Res; 2020 Mar; 48(3):300060520909776. PubMed ID: 32216489
[TBL] [Abstract][Full Text] [Related]
13. ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway.
Zhan W; Li Y; Liu X; Zheng C; Fu Y
Cancer Manag Res; 2020; 12():599-610. PubMed ID: 32158264
[TBL] [Abstract][Full Text] [Related]
14. TRIP6 enhances stemness property of breast cancer cells through activation of Wnt/β-catenin.
Zhao X; Jiang C; Xu R; Liu Q; Liu G; Zhang Y
Cancer Cell Int; 2020; 20():51. PubMed ID: 32082081
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of XB130 restrains cancer stem cell-like phenotype through inhibition of Wnt/β-Catenin signaling in breast cancer.
Xie T; Jiang C; Dai T; Xu R; Zhou X; Su X; Zhao X
Mol Carcinog; 2019 Oct; 58(10):1832-1845. PubMed ID: 31219645
[TBL] [Abstract][Full Text] [Related]
16. LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling.
Yang L; Tang H; Kong Y; Xie X; Chen J; Song C; Liu X; Ye F; Li N; Wang N; Xie X
Stem Cells; 2015 Oct; 33(10):2913-24. PubMed ID: 26086949
[TBL] [Abstract][Full Text] [Related]
17. Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells.
Ilmer M; Mazurek N; Gilcrease MZ; Byrd JC; Woodward WA; Buchholz TA; Acklin K; Ramirez K; Hafley M; Alt E; Vykoukal J; Bresalier RS
Breast Cancer Res; 2016 Sep; 18(1):97. PubMed ID: 27687248
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
